Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

7.6. Analysis.

Comparison 7 Non‐comparative studies: proportion of participants with non‐serious adverse events, Outcome 6 Immune system.

Immune system
Study Symptom Adverse events/total number of participants
Nasopharyngitis
Arnold 2004 Rhinitis 5/76
Arnold 2010 Rhinitis 6/150
Döpfner 2011b Rhinitis 2/113
Findling 2009 Rhinitis 24/157
Kratochvil 2002 Rhinitis 8/25
Pyrexia
Arnold 2004 Fever 7/89
Findling 2009 Fever 33/157
Wang 2007 Pyrexia 17/166
Allergies
Hammerness 2009 Allergies 3/154
Pierce 2010 Pruritis 2/71
Cold symptoms
Hammerness 2009 Cold symptoms 2/57
Kratochvil 2002 Fever + flu syndrome 8/25
Steele 2006 Flu‐like symptoms 7/72
Pharyngitis
Arnold 2004 Pharyngitis 10/76
Döpfner 2011b Pharyngitis 2/113
Kordon 2011 Pharyngitis 6/541
Kratochvil 2002 Pharyngitis 3/25
Sangal 2006 Pharyngitis 7/79
Viral infection
Arnold 2004 Viral infection 18/76
Kordon 2011 Viral infection 8/598
Rash
Arnold 2004 Rash 6/76
Garg 2014 Rash 1/27
Lee 2007 Rash 4/110
Rhinitis
Arnold 2004 Rhinitis 5/76
Kordon 2011 Rhinitis 8/541
Ear disorders
Hammerness 2009 Ear pain 3/57
Fever
Kordon 2011 Fever 9/541
Infections
Valdizán Usón 2013 Nonspecific pathogen 13/689